Eight Roads Venture’s $37 Milion Series B Financing in Insilico Medicine

Sidley Austin represented Eight Roads Ventures.

Sidley represented Eight Roads Ventures as an investor in Insilico Medicine’s US$37 million Series B funding round. Insilico Medicine is engaged in developing next-generation artificial intelligence technology for drug discovery. The financing round included Eight Roads Ventures, F-Prime Capital, Qiming Venture Partners, Lilly Asia Ventures, Sinovation Ventures, Baidu Ventures, Pavilion Capital, Bold Capital Partners and other Series A investors.

The Sidley team was led by partner Ruchun Ji (Picture) with assistance from associate Henry Cao.

Involved fees earner: Henry Cao – Sidley Austin LLP; Ruchun Ji – Sidley Austin LLP;

Law Firms: Sidley Austin LLP;

Clients: Eight Roads Ventures;

Author: Ambrogio Visconti